Pharma's BRIC Building
The health care industry's biggest conference just finished up, and the Fool's health care team was keeping close watch. While much of the interest was focused on biotech outfits big and small, the industry's titans -- the big pharmaceutical companies -- made some noise of their own.
Our health care bureau chief, Brenton Flynn, listened in on seven big pharmaceutical companies that made an appearance, and in the following video he dives into one major area of focus for nearly every company: emerging-markets growth.
Over the next two years, Eli Lilly will see nearly $0.40 of every $1.00 in sales exposed to generic competition. How does the company plan to respond to this huge patent cliff? Better yet, what does this mean for investors? In a brand new premium report on Eli Lilly, The Motley Fool's top pharmaceuticals analyst delves into everything investors need to know about the stock today. Simply click here now to claim your copy.
The article Pharma's BRIC Building originally appeared on Fool.com.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
